东莨菪碱对大鼠强迫游泳行为的影响及其作用靶点

doi:10.3969/j.issn.1006-7795.2018.05.002

首都医科大学学报 ›› 2018, Vol. 39 ›› Issue (5): 630-635.doi: 10.3969/j.issn.1006-7795.2018.05.002

• 精神病学基础和临床研究 • 上一篇下一篇

东莨菪碱对大鼠强迫游泳行为的影响及其作用靶点

时丹丹, 杨健, 张金钮, 王刚

首都医科大学附属北京安定医院国家精神心理疾病临床医学研究中心精神疾病诊断与治疗北京市重点实验室, 北京 100088

收稿日期:2018-07-03 出版日期:2018-09-21 发布日期:2018-10-20
通讯作者: 王刚 E-mail:gangwangdoc@yeah.net
基金资助:
国家自然科学基金（81601185），国家重点研发计划（2016YFC1307200），国家重点基础研究发展计划项目（2014CB744601）。

Effects of scopolamine on forced swimming behavior in rats and its possible action target

Shi Dandan, Yang Jian, Zhang Jinniu, Wang Gang

National Clinical Research Center for Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing Key Laboratory of Mental Disorders, Beijing 100088, China

Received:2018-07-03 Online:2018-09-21 Published:2018-10-20
Supported by:
This study was supported by National Natural Science Foundation of China (81601185),National Key Research & Development Program of China (2016YFC1307200),Major State Basic Research Development Program of China (2014CB744601).

摘要/Abstract

摘要： 目的阐明东莨菪碱发挥抗抑郁作用的可能脑区和靶点。方法明确东莨菪碱的抗抑郁样作用：将正常Sprague Dawley （SD）大鼠采用数字表法随机分为东莨菪碱组和0.9%（质量分数）氯化钠注射液对照组，腹腔注射25 μg/kg东莨菪碱或等体积0.9%（质量分数）氯化钠注射液，24 h后进行旷场实验和强迫游泳实验以评价东莨菪碱对大鼠抑郁样行为的影响；明确东莨菪碱发挥抗抑郁效应的脑区：在腹腔注射25 μg/kg东莨菪碱前1 h向大鼠内侧前额叶皮质（medial prefrontal cortex，mPFC）立体定位注射γ-氨基丁酸-A （γ-aminobutyric acid-A，GABA-A）受体激动剂蝇蕈醇（Muscimol）1.25 μg，24 h后观察东莨菪碱的行为学效应是否被阻断；探索东莨菪碱抗抑郁的作用靶点：通过微量给药系统分批次分别向大鼠侧脑室注射毒蕈碱型乙酰胆碱受体2（muscarinic acetylcholine receptor 2，M₂）选择性拮抗剂（methoctramine，MCT）0.5、1和2 μg，对照组均给予2 μL 0.9%（质量分数）氯化钠注射液，24 h后利用旷场实验和强迫游泳测试评价大鼠行为学变化。结果腹腔注射东莨菪碱24 h后，大鼠强迫游泳不动时间低于对照组（P<0.05），旷场总路程差异无统计学意义（P>0.05）；向mPFC注射Muscimol可明显增加东莨菪碱组大鼠的不动时间（P<0.01），旷场总路程差异无统计学意义（P>0.05）；与侧脑室注射0.9%（质量分数）氯化钠注射液相比，0.5 μg MCT不影响大鼠在强迫游泳实验中不动时间（P>0.05），1 μg MCT可明显降低影响大鼠不动时间（P<0.01），而2 μg MCT则可明显增加影响大鼠不动时间（P<0.05）。结论东莨菪碱可能通过阻断mPFC的M₂受体发挥抗抑郁作用。

关键词: 抑郁症, 东莨菪碱, 毒蕈碱型乙酰胆碱受体, 强迫游泳

Abstract: Objective To clarify the possible brain regions and targets to mediate antidepressant-like effects of scopolamine. Methods Sprague Dawley (SD) rats were randomly divided into scopolamine group and saline control group. The rats were intraperitoneally injected with scopolamine or equal volume saline. After 24 hours, open field test and forced swimming test were carried out to evaluate the effect of scopolamine on the behavior of rats. γ-Aminobutyric acid-A (GABA-A) receptor agonist Muscimol (1.25 μg)was stereotaxically injected into the medial prefrontal cortex (mPFC) of rats one hour before intraperitoneal injection of 25 μg/kg scopolamine. Behavioral effects were examined after 24 hours. 0.5 μg, 1 μg and 2 μg muscarinic acetylcholine receptor 2 (M₂) receptor selective antagonist methoctramine (MCT) were respectively injected into the lateral ventricle of rats by the micro dosing system, while the control group was given 2 μL saline. Behavioral effects were examined after 24 hours. Results After 24 hours of intraperitoneal injection of scopolamine, the immobility time in rats was lower than that in the control group (P<0.05), while no statistical difference was observed in the total distance of the open field (P>0.05). In Muscimol+scopolamine group, the immobility time in rats was significantly higher than that in scopolamine group (P<0.01). No statistical difference was observed in the total distance in the open field test (P>0.05). Compared with lateral ventricle injection of saline, 0.5 μg MCT had no effect on the immobility time (P>0.05), 1 μg MCT could significantly reduce the immobility time (P<0.01), whereas 2 μg MCT could significantly increase the immobility time (P<0.05). Conclusion Scopolamine may exert antidepressant-like effects by blocking the M₂ receptor of mPFC.

Key words: depression, scopolamine, muscarinic acetylcholine receptor, forced swimming test

中图分类号:

R749.4

时丹丹, 杨健, 张金钮, 王刚. 东莨菪碱对大鼠强迫游泳行为的影响及其作用靶点[J]. 首都医科大学学报, 2018, 39(5): 630-635.

Shi Dandan, Yang Jian, Zhang Jinniu, Wang Gang. Effects of scopolamine on forced swimming behavior in rats and its possible action target[J]. Journal of Capital Medical University, 2018, 39(5): 630-635.

参考文献

[1] Friedrich M J. Depression is the leading cause of disability around the world[J]. JAMA, 2017, 317(15):1517.
[2] Trivedi M H, Rush A J, Wisniewski S R, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D:implications for clinical practice[J]. Am J Psychiatr, 2006, 163(1):28-40.
[3] 王刚. 抗抑郁药的起效时间[J]. 中华精神科杂志,2011(1):49-50.
[4] Furey M L, Drevets W C. Antidepressant efficacy of the antimuscarinic drug scopolamine:a randomized, placebo-controlled clinical trial[J]. Arch Gen Psychiatr, 2006, 63(10):1121-1129.
[5] Gillin J C, Sutton L, Ruiz C, et al. The effects of scopolamine on sleep and mood in depressed patients with a history of alcoholism and a normal comparison group[J]. Biol Psychiatr, 1991, 30(2):157-169.
[6] Gibbons A S, Jeon W J, Scarr E, et al. Changes in muscarinic M2 receptor levels in the cortex of subjects with bipolar disorder and major depressive disorder and in rats after treatment with mood stabilisers and antidepressants[J]. Int J Neuropsychopharmacol, 2016, 19(4).
[7] Gibbons A S, Scarr E, McLean C, et al. Decreased muscarinic receptor binding in the frontal cortex of bipolar disorder and major depressive disorder subjects[J]. J Affect Disord, 2009, 116(3):184-191.
[8] Comings D E, Wu S, Rostamkhani M, et al. Association of the muscarinic cholinergic 2 receptor (CHRM2) gene with major depression in women[J]. Am J Med Genet, 2002, 114(5):527-529.
[9] Wang J C, Hinrichs A L, Stock H, et al. Evidence of common and specific genetic effects:association of the muscarinic acetylcholine receptor M2(CHRM2) gene with alcohol dependence and major depressive syndrome[J]. Hum Mol Genet, 2004, 13(17):1903-1911.
[10] Drevets W C, Price J L, Furey M L. Brain structural and functional abnormalities in mood disorders:implications for neurocircuitry models of depression[J]. Brain Struct Funct, 2008, 213(1-2):93-118.
[11] MacQueen G M, Yucel K, Taylor V H, et al. Posterior hippocampal volumes are associated with remission rates in patients with major depressive disorder[J]. Biol Psychiatry, 2008, 64(10):880-883.
[12] Li N, Lee B, Liu R J, et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists[J]. Science, 2010, 329(5994):959-964.
[13] Navarria A, Wohleb E S, Voleti B, et al. Rapid antidepressant actions of scopolamine:Role of medial prefrontal cortex and M1-subtype muscarinic acetylcholine receptors[J]. Neurobiol Dis, 2015, 82:254-261.
[14] Witkin J M, Overshiner C, Li X, et al. M1 and m2 muscarinic receptor subtypes regulate antidepressant-like effects of the rapidly acting antidepressant scopolamine[J]. J Pharmacol Exp Ther, 2014, 351(2):448-456.
[15] Chau D T, Rada P, Kosloff R A, et al. Nucleus accumbens muscarinic receptors in the control of behavioral depression:antidepressant-like effects of local M1 antagonist in the Porsolt swim test[J]. Neuroscience, 2001, 104(3):791-798.
[16] Dong J, Zhou Q, Wei Z, et al. Protein kinase A mediates scopolamine-induced mTOR activation and an antidepressant response[J]. J Affect Disord, 2018, 227:633-642.
[17] Lucas-Meunier E, Fossier P, Baux G, et al. Cholinergic modulation of the cortical neuronal network[J]. Pflugers Arch, 2003, 446(1):17-29.
[18] Medalla M, Barbas H. The anterior cingulate cortex may enhance inhibition of lateral prefrontal cortex via m2 cholinergic receptors at dual synaptic sites[J]. J Neurosci, 2012, 32(44):15611-15625.
[19] Voleti B, Navarria A, Liu R J, et al. Scopolamine rapidly increases mammalian target of rapamycin complex 1 signaling, synaptogenesis, and antidepressant behavioral responses[J]. Biol Psychiatry, 2013, 74(10):742-749.
[20] Chen Z, Huang C, Ding W. Z-Guggulsterone improves the scopolamine-induced memory impairments through enhancement of the BDNF signal in C57BL/6J Mice[J]. Neurochem Res, 2016, 41(12):3322-3332.
[21] Park H R, Lee H, Park H, et al. Fermented sipjeondaebo-tang alleviates memory deficits and loss of hippocampal neurogenesis in scopolamine-induced amnesia in mice[J]. Sci Rep, 2016, 6:22405.
[22] Yu H, Li M, Shen X, et al. The requirement of L-Type voltage-dependent calcium channel (L-VDCC) in the rapid-acting antidepressant-like effects of scopolamine in mice[J]. Int J Neuropsychopharmacol, 2018, 21(2):175-186.
[23] Bhattacharya S K, Sen A P. Effects of muscarinic receptor agonists and antagonists on swim-stress-induced ‘behavioural despair’ in rats[J]. J Psychopharmacol, 1991, 5(1):77-81.

东莨菪碱对大鼠强迫游泳行为的影响及其作用靶点

Effects of scopolamine on forced swimming behavior in rats and its possible action target

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	孙丛丛, 吴涵, 周丹娜, 姜玮, 王雯, 杨春林, 马辛, 任艳萍. 脑源性神经营养因子对经颅磁刺激治疗难治性抑郁症的疗效预测作用[J]. 首都医科大学学报, 2022, 43(2): 227-232.
[2]	王建平, 桂沛君, 谢瑛. 经颅直流电刺激治疗轻中度老年抑郁症的临床观察[J]. 首都医科大学学报, 2019, 40(6): 948-952.
[3]	李苗, 王群松, 袁国桢. 金匮肾气丸治疗肾虚肝郁型抑郁症的治疗效果及其对人血清神经生长因子的影响[J]. 首都医科大学学报, 2019, 40(2): 220-225.
[4]	唐利荣, 郑伟, 赵秀芹, 任艳萍, 向应强, 高越, 徐秋月, 马辛. 康复技能训练对抑郁症患者症状缓解和生活质量的作用[J]. 首都医科大学学报, 2018, 39(5): 636-640.
[5]	李苗, 袁国桢, 王群松, 周振和, 刘亮. 金匮肾气丸改善抑郁症病人疲劳感的临床研究[J]. 首都医科大学学报, 2017, 38(2): 197-201.
[6]	王群松, 季向东, 朱文娴, 于海燕. 针刺治疗对阴虚火旺型抑郁症的血清BDNF影响[J]. 首都医科大学学报, 2016, 37(2): 176-180.
[7]	谭赛, 雷小明, 王彦云, 潘菊华, 张颖, 黄世敬, 张永超, 郑军, 陈朝, 陈宇霞, 李多娇. 基于慢性缺血应激建立血管性抑郁症动物模型[J]. 首都医科大学学报, 2016, 37(2): 196-202.
[8]	尹梦雅, 贾竑晓, 朱虹, 刘嘉. 抑郁症患者的自我面孔识别研究[J]. 首都医科大学学报, 2013, 34(2): 207-210.
[9]	袁海宁, 贾竑晓, 朱虹, 田金洲, 时晶. “清热解郁方”合并氟西汀治疗难治性抑郁症的疗效观察[J]. 首都医科大学学报, 2013, 34(2): 211-213.
[10]	林贤浩;郑金炽. 慢性强迫游泳对大鼠行为及其脑内突触后致密蛋白95含量的影响[J]. 首都医科大学学报, 2011, 32(6): 820-824.
[11]	李丽;丁妮;薛峰;梅磊磊;董奇. 单相抑郁症患者临床症状与脑功能异常的关联研究[J]. 首都医科大学学报, 2009, 30(1): 32-36.
[12]	孙菲;汤哲;刘富荣;刁丽军;刘宏军;关绍晨;吴晓光. 北京市城乡老年人常见慢性疾病对抑郁症状发病率的影响[J]. 首都医科大学学报, 2008, 29(3): 283-287.
[13]	潘菊华;王彦云;黄世敬;毛艳荣;陈朝;郑军;李多娇;崔翰明. 血管性抑郁大鼠模型的建立[J]. 首都医科大学学报, 2007, 28(6): 760-762.
[14]	刘宏军;赵利杰;丁晖;陈彪. 帕金森病抑郁状态的发生率及相关因素研究[J]. 首都医科大学学报, 2007, 28(3): 370-372.
[15]	卜力;李凌;李占江. 老年抑郁症的临床特点[J]. 首都医科大学学报, 2006, 27(3): 410-413.